Evolus (EOLS) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
11 Jun, 2026Opening remarks and agenda
Meeting opened with introductions of executive management, legal counsel, and representatives from the independent auditor and election inspector.
Confirmation of proper notice to stockholders and establishment of quorum.
Meeting conducted virtually with adherence to published rules of conduct.
Shareholder proposals
Election of two class 2 directors to serve until the 2029 annual meeting.
Ratification of Ernst & Young as independent registered public accounting firm for fiscal year ending December 31, 2026.
Advisory approval of named executive officer compensation.
Overview of voting outcomes
All proposals, including director elections, auditor ratification, and executive compensation, were approved by shareholders.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Evolus
- Shelf registration allows up to $250M in securities offerings for the cash-pay aesthetic market.EOLS
Registration filing5 Jun 2026 - Diversified aesthetics portfolio, digital scale, and innovation drive growth and profitability.EOLS
Jefferies Global Healthcare Conference 20264 Jun 2026 - Q1 2026 saw 7% revenue growth, positive Adjusted EBITDA, and reaffirmed full-year guidance.EOLS
Q1 202611 May 2026 - Portfolio expansion, market recovery, and loyalty programs drive strong growth outlook.EOLS
Leerink Global Healthcare Conference 20266 May 2026 - Double-digit growth and digital innovation drive sustained profitability and market expansion.EOLS
Investor presentation4 May 2026 - Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.EOLS
Proxy filing29 Apr 2026 - Votes include director elections, auditor ratification, and executive pay approval.EOLS
Proxy filing29 Apr 2026 - Double-digit growth, expanding HA portfolio, and Sculpt approval set the stage for 2026-2028.EOLS
25th Annual Needham Virtual Healthcare Conference14 Apr 2026 - Low-cost, quality-driven cannabis operator targets rapid, profitable multi-state growth.EOLS
Investor presentation10 Apr 2026